SignatureFD’s ResMed RMD Stock Holding History

SignatureFD’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$969K	Buy	4,315 +92	+2%	+$22.9K	0.01%	405
2025 Q4	$1.02M	Buy	4,223 +17	+0.4%	+$4.35K	0.02%	374
2025 Q3	$1.15M	Sell	4,206 -11	-0.3%	-$3K	0.02%	345
2025 Q2	$1.09M	Sell	4,217 -308	-7%	-$73.5K	0.02%	333
2025 Q1	$1.01M	Buy	4,525 +319	+8%	+$74.5K	0.02%	339
2024 Q4	$962K	Sell	4,206 -5	-0.1%	-$1.2K	0.02%	346
2024 Q3	$1.03M	Buy	4,211 +72	+2%	+$16.1K	0.02%	325
2024 Q2	$792K	Sell	4,139 -366	-8%	-$74.3K	0.02%	370
2024 Q1	$892K	Buy	4,505 +192	+4%	+$35.2K	0.02%	339
2023 Q4	$742K	Buy	4,313 +1,555	+56%	+$239K	0.02%	358
2023 Q3	$408K	Buy	2,758 +287	+12%	+$51.9K	0.01%	511
2023 Q2	$540K	Buy	2,471 +103	+4%	+$23K	0.01%	417
2023 Q1	$519K	Sell	2,368 -146	-6%	-$31.7K	0.01%	422
2022 Q4	$523K	Sell	2,514 -702	-22%	-$154K	0.02%	403
2022 Q3	$702K	Buy	3,216 +512	+19%	+$117K	0.02%	278
2022 Q2	$567K	Buy	2,704 +594	+28%	+$126K	0.02%	342
2022 Q1	$512K	Buy	2,110 +239	+13%	+$57.8K	0.02%	394
2021 Q4	$487K	Buy	1,871 +49	+3%	+$12.7K	0.02%	406
2021 Q3	$480K	Buy	1,822 +198	+12%	+$54.1K	0.02%	383
2021 Q2	$400K	Buy	1,624 +31	+2%	+$6.52K	0.02%	429
2021 Q1	$309K	Buy	1,593 +565	+55%	+$113K	0.01%	440
2020 Q4	$219K	Buy	1,028 +22	+2%	+$4.39K	0.01%	506
2020 Q3	$172K	Sell	1,006 -43	-4%	-$7.94K	0.01%	537
2020 Q2	$201K	Buy	1,049 +144	+16%	+$23.6K	0.01%	446
2020 Q1	$133K	Buy	905 +274	+43%	+$43.6K	0.01%	536
2019 Q4	$98K	Buy	631 +183	+41%	+$26.4K	0.01%	714
2019 Q3	$61K	Buy	448 +191	+74%	+$25K	0.01%	852
2019 Q2	$31K	Buy	257 +24	+10%	+$2.66K	﹤0.01%	1062
2019 Q1	$24K	Sell	233 -567	-71%	-$58.5K	﹤0.01%	1127
2018 Q4	$91K	Buy	800 +231	+41%	+$24.8K	0.01%	622
2018 Q3	$66K	Buy	569 +11	+2%	+$1.21K	0.01%	782
2018 Q2	$58K	Sell	558 -6	-1%	-$607	0.01%	804
2018 Q1	$56K	Buy	+564	New	+$53.3K	0.01%	700
2016 Q4	–	Sell	-474	Closed	-$31K	–	997
2016 Q3	$31K	Hold	474	–	–	﹤0.01%	672
2016 Q2	$30K	Buy	474 +20	+4%	+$1.18K	﹤0.01%	608
2016 Q1	$26K	Hold	454	–	–	﹤0.01%	595
2015 Q4	$24K	Hold	454	–	–	﹤0.01%	523
2015 Q3	$23K	Buy	454 +54	+14%	+$2.91K	0.01%	496
2015 Q2	$23K	Hold	400	–	–	0.01%	443
2015 Q1	$29K	Hold	400	–	–	0.01%	373
2014 Q4	$22K	Buy	+400	New	+$20.9K	0.01%	401

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SignatureFD's RMD Position: Q1 2026 in Review

SignatureFD increased its ResMed (RMD) stake by 2.2% in Q1 2026, buying an estimated $22.9K and bringing the position to 4,315 shares worth $969K. The position accounts for 0.01% of the portfolio, ranked #405.

SignatureFD first reported a position in RMD in Q4 2014 and has held it in 41 quarters since. The position peaked at $1.15M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

SignatureFD held 4,315 shares of ResMed worth $969K as of Q1 2026.
SignatureFD bought 92 ResMed shares in Q1 2026, an estimated $22.9K.
ResMed made up 0.01% of SignatureFD's portfolio in Q1 2026, its #405 holding.
SignatureFD first reported a position in ResMed in Q4 2014 and has held it in 41 quarters since.
SignatureFD's ResMed position peaked at $1.15M in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.